Investors / Israel / T3 – Technion Technology Transfer
T3 – Technion Technology Transfer
Investor · Haifa, Israel · Middle East and Africa
T3 is the technology transfer organization of the Technion, commercializing research-based inventions across technology domains. It offers commercialization tracks including the T:start Accelerator and works with spinoffs and industry partners.
Invests inHealthcare & BiotechAI & Machine Learning
In its own wordstechnology transferdeep techacceleratoruniversity spinoffscommercialization
Your fit with T3 – Technion Technology Transfer
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsT3 – Technion Technology Transfer lists 4 checked portfolio companies on its own site and is named in 1 funding round. Its most frequent entry is Seed, 100% of the companies with a known first round. Its largest themes are Healthcare & Biotech (67%) and AI & Machine Learning (33%). 67% of its companies are based in Israel. It invests most often alongside Andreessen Horowitz, Base4 Capital LP and Clay Capital.
Counts come from funding rounds that name T3 – Technion Technology Transfer, complete from mid-2025: earlier rounds appear only when they were reported later. Round amounts and full round histories are on Fundup AI.
Entry stage
share of companies by the stage of its first roundT3 – Technion Technology Transfer does not state its stages on its site, so only what it does is shown.
Show as a table
| Value | |
|---|---|
| Pre-seed | 0% |
| Seed | 100% |
| Series A | 0% |
| Series B | 0% |
| Growth | 0% |
Activity by year
rounds it joined, last 10 yearsShow as a table
| Total | Rounds it led | |
|---|---|---|
| '17 | 0 | 0 |
| '18 | 0 | 0 |
| '19 | 0 | 0 |
| '20 | 0 | 0 |
| '21 | 0 | 0 |
| '22 | 0 | 0 |
| '23 | 1 | 0 |
| '24 | 0 | 0 |
| '25 | 0 | 0 |
| '26 | 0 | 0 |
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| Andreessen Horowitz | 1 |
| Base4 Capital LP | 1 |
| Clay Capital | 1 |
| LionBird | 1 |
| NFX | 1 |
| New Gate Capital | 1 |
| Rabo Investments | 1 |
| S2G Investments | 1 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers4100%
- No longer answers00%
- Points to another company00%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 67% | 15% |
| AI & Machine Learning | 33% | 18% |
Co-investor network
who it backs companies with, and who they back togetherAll co-investors or Compare portfolios with Andreessen Horowitz
Compare T3 – Technion Technology Transfer head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Recent portfolio activity
when companies last raised with T3 – Technion Technology Transfer| Date | Company | Stage |
|---|---|---|
| 10 Oct 2023 | Seed |
Round details for T3 – Technion Technology Transfer
Amounts, full round histories and every co-investor in T3 – Technion Technology Transfer's rounds are on Fundup AI. VCinfo covers investors and their portfolios.
Portfolio
4 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| Mana.bio is an AI based drug delivery startup, focusing on gene therapy including DNA and RNA-based therapeutics, and vaccines. | Healthcare & Biotech | Oct 2023Seed | Page + round | |
| NanoGhost develops a drug targeting platform from the cell membrane of mesenchymal stem cells | Healthcare & Biotech | Portfolio page | ||
| Sleep.ai develops and provides sleep-related products and services, including sleep measurement and tracking tools, to individuals and businesses. | Healthcare & BiotechAI & Machine Learning | Portfolio page | ||
| ViAqua develops an orally administered particle-based platform for the delivery of RNA to improve resistance against diseases in aquaculture species | Healthcare & BiotechAI & Machine Learning | Portfolio page |
About this data
site last read 11 Nov 2026- Site
- technion.ac.il
- Last read
- 11 Nov 2026
- Watching since
- 11 Nov 2026
- Rounds since
- 10 Oct 2023
- Companies checked
- 4
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get T3 – Technion Technology Transfer's profile as data
Pull T3 – Technion Technology Transfer's portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/technion.ac.il
# also
GET /v1/firms/technion.ac.il/portfolio
GET /v1/firms/technion.ac.il/coinvestors
GET /v1/firms/technion.ac.il/news